TP53 and B-cell chronic lymphocytic leukemia: Thirdly, CLL cells carrying mutant p53 have an impaired ability to manage oxidative stress and are more prone to accumulating ROS following PRIMA-1Met and SAS treatment than wt p53-carrying cells.